Literature DB >> 17986384

Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration.

Ching-wen Cheng1, Ju-ching Yeh, Tai-Ping Fan, Stephen K Smith, D Stephen Charnock-Jones.   

Abstract

Cell to cell interaction is one of the key processes effecting angiogenesis and endothelial cell function. Wnt signalling is mediated through cell-cell interaction and is involved in many developmental processes and cellular functions. In this study, we investigated the possible function of Wnt5a and the non-canonical Wnt pathway in human endothelial cells. We found that Wnt5a-mediated non-canonical Wnt signalling regulated endothelial cell proliferation. Blocking this pathway using antibody, siRNA or a down-stream inhibitor led to suppression of endothelial cell proliferation, migration, and monolayer wound closure. We also found that the mRNA level of Wnt5a is up-regulated when endothelial cells are treated with a cocktail of inflammatory cytokines. Our findings suggest non-canonical Wnt signalling plays a role in regulating endothelial cell growth and possibly in angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986384     DOI: 10.1016/j.bbrc.2007.10.166

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  60 in total

Review 1.  The Wnt signaling pathway: aging gracefully as a protectionist?

Authors:  Kenneth Maiese; Faqi Li; Zhao Zhong Chong; Yan Chen Shang
Journal:  Pharmacol Ther       Date:  2008-02-11       Impact factor: 12.310

2.  WNT5A selectively inhibits mouse ventral prostate development.

Authors:  Sarah Hicks Allgeier; Tien-Min Lin; Chad M Vezina; Robert W Moore; Wayne A Fritz; Shing-Yan Chiu; ChuanLi Zhang; Richard E Peterson
Journal:  Dev Biol       Date:  2008-08-29       Impact factor: 3.582

Review 3.  The murine allantois: a model system for the study of blood vessel formation.

Authors:  Ripla Arora; Virginia E Papaioannou
Journal:  Blood       Date:  2012-07-31       Impact factor: 22.113

Review 4.  Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.

Authors:  Tura C Camilli; Ashani T Weeraratna
Journal:  Biochem Pharmacol       Date:  2010-03-06       Impact factor: 5.858

5.  Disruption of Wnt planar cell polarity signaling by aberrant accumulation of the MetAP-2 substrate Rab37.

Authors:  Thomas B Sundberg; Nicole Darricarrere; Pasquale Cirone; Xia Li; Lucy McDonald; Xue Mei; Christopher J Westlake; Diane C Slusarski; Robert J Beynon; Craig M Crews
Journal:  Chem Biol       Date:  2011-10-28

6.  When it is hard to get to with genetics--planar cell polarity under a chemical scalpel.

Authors:  Yimin Zou
Journal:  Chem Biol       Date:  2011-11-23

7.  P2Y1 and P2Y13 purinergic receptors mediate Ca2+ signaling and proliferative responses in pulmonary artery vasa vasorum endothelial cells.

Authors:  Taras Lyubchenko; Heather Woodward; Kristopher D Veo; Nana Burns; Hala Nijmeh; Ganna A Liubchenko; Kurt R Stenmark; Evgenia V Gerasimovskaya
Journal:  Am J Physiol Cell Physiol       Date:  2010-10-20       Impact factor: 4.249

8.  Dkk-1 inhibits intestinal epithelial cell migration by attenuating directional polarization of leading edge cells.

Authors:  Stefan Koch; Christopher T Capaldo; Stanislav Samarin; Porfirio Nava; Irmgard Neumaier; Arne Skerra; David B Sacks; Charles A Parkos; Asma Nusrat
Journal:  Mol Biol Cell       Date:  2009-09-23       Impact factor: 4.138

9.  Wntless is required for peripheral lung differentiation and pulmonary vascular development.

Authors:  Bridget Cornett; John Snowball; Brian M Varisco; Richard Lang; Jeffrey Whitsett; Debora Sinner
Journal:  Dev Biol       Date:  2013-03-21       Impact factor: 3.582

10.  Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Jinling Hou; Kenneth Maiese
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.